MAPT and Alzheimer disease: Glycogen synthase kinase-3β (GSK3β) is one of the most important kinases due to its ability to phosphorylate tau at the majority of its serine/threonine sites, which cause associated toxicities in AD (Medina et al., 2011; Llorens-Martín et al., 2014).